Shiga toxin-producing Escherichia coli (STEC) stool multiplex PCR can replace culture for clinical diagnosis and follow-up.

Autor: Jääskeläinen AE; Department of Clinical Microbiology, HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Salmenlinna S; Expert Microbiology Unit, Department of Health Security, Finnish Institute for Health and Welfare, Helsinki, Finland., Antikainen J; Department of Clinical Microbiology, HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Sihvonen R; Department of Clinical Microbiology, HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Ahava M; Department of Clinical Microbiology, HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Tarkka E; Department of Clinical Microbiology, HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Pätäri-Sampo A; Department of Clinical Microbiology, HUSLAB, HUS Diagnostic Center, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

Publikováno v: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica [APMIS] 2023 Jul; Vol. 131 (7), pp. 333-338. Date of Electronic Publication: 2023 Apr 26.

Outbreak of Listeria monocytogenes in hospital linked to a fava bean product, Finland, 2015 to 2019.

Autor: Otte Im Kampe E; ECDC Fellowship Programme, Field Epidemiology path (EPIET), European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.; Finnish Institute for Health and Welfare (THL), Helsinki, Finland., Salmenlinna S; Finnish Institute for Health and Welfare (THL), Helsinki, Finland., Åberg R; Food Safety Unit, Environmental Services, City of Helsinki, Finland., Wallgren S; Finnish Food Authority (FFA), Helsinki, Finland., Hautaniemi M; Finnish Food Authority (FFA), Helsinki, Finland., Keronen S; Abdominal Center, Department of Nephrology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland., Leinonen E; Finnish Food Authority (FFA), Helsinki, Finland., Pihlajasaari A; Finnish Food Authority (FFA), Helsinki, Finland., Ruotsalainen E; Division of Infectious Diseases, Inflammation Center, HUS Helsinki University Hospital, Helsinki, Finland., Sarvela A; Environmental office, City of Seinäjoki, Seinäjoki, Finland., Rimhanen-Finne R; Finnish Institute for Health and Welfare (THL), Helsinki, Finland.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 May; Vol. 29 (19).

Campylobacteriosis in Finland: Passive Surveillance in 2004-2021 and a Pilot Case-Control Study with Whole-Genome Sequencing in Summer 2022.

Autor: Suominen K; Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271 Helsinki, Finland., Häkkänen T; Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271 Helsinki, Finland., Ranta J; Risk Assessment Unit, Finnish Food Authority, Mustialankatu 3, 00790 Helsinki, Finland., Ollgren J; Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271 Helsinki, Finland., Kivistö R; Department of Food Hygiene and Environmental Health, Faculty of Veterinary Medicine, University of Helsinki, Agnes Sjöbergin katu 2, 00790 Helsinki, Finland., Perko-Mäkelä P; Atria Plc, Itikanmäenkatu 3, 60100 Seinäjoki, Finland., Salmenlinna S; Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271 Helsinki, Finland., Rimhanen-Finne R; Department of Health Security, Finnish Institute for Health and Welfare, Mannerheimintie 166, 00271 Helsinki, Finland.

Publikováno v: Microorganisms [Microorganisms] 2024 Jan 09; Vol. 12 (1). Date of Electronic Publication: 2024 Jan 09.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Hemolytic uremic syndrome caused by Shiga toxin–producing Escherichia coli in children:incidence, risk factors, and clinical outcome

Autor: Ylinen, E. (Elisa), Salmenlinna, S. (Saara), Halkilahti, J. (Jani), Jahnukainen, T. (Timo), Korhonen, L. (Linda), Virkkala, T. (Tiia), Rimhanen-Finne, R. (Ruska), Nuutinen, M. (Matti), Kataja, J. (Janne), Arikoski, P. (Pekka), Linkosalo, L. (Laura), Bai, X. (Xiangning), Matussek, A. (Andreas), Jalanko, H. (Hannu), Saxén, H. (Harri)

Background: Hemolytic uremic syndrome (HUS) is a multisystemic disease. In a nationwide study, we characterized the incidence, clinical course, and prognosis of HUS caused by Shiga toxin (Stx)–producing Escherichia coli (STEC) strains with emphasis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2423::069d0970764f2007222c088c8c55ba89
http://urn.fi/urn:nbn:fi-fe2020091769942